Relationship Between Hospital Mortality and Readmission Rates After Transcatheter Aortic Valve Replacement.

IF 4.8 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European Heart Journal - Quality of Care and Clinical Outcomes Pub Date : 2024-11-30 DOI:10.1093/ehjqcco/qcae102
Dhaval Kolte, Archana Tale, Yang Song, Robert W Yeh
{"title":"Relationship Between Hospital Mortality and Readmission Rates After Transcatheter Aortic Valve Replacement.","authors":"Dhaval Kolte, Archana Tale, Yang Song, Robert W Yeh","doi":"10.1093/ehjqcco/qcae102","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is substantial hospital-level variation in 30-day risk-standardized mortality rate (RSMR) and risk-standardized readmission rate (RSRR) after transcatheter aortic valve replacement (TAVR). However, the relationship between hospital RSMRs and RSRRs has not been well characterized.</p><p><strong>Methods: </strong>We analyzed data on 141,905 Medicare fee-for-service beneficiaries who underwent TAVR across 512 hospitals between October 1, 2015 and December 31, 2020. The primary and secondary outcomes of interest were 30-day all-cause mortality and 30-day all-cause readmissions, respectively. Hierarchical logistic regression models with random hospital-level intercepts were used to estimate RSMRs and RSRRs for each hospital. We used Pearson correlation coefficient (r) and restricted cubic spline regression to determine the relationship between RSMR and RSRR in the overall cohort and within subgroups based on hospital characteristics.</p><p><strong>Results: </strong>The median (IQR) hospital-level 30-day RSMR was 2.2% (2.1%-2.4%), ranging from 1.3% to 3.5%. Similarly, the median (IQR) hospital-level 30-day RSRR was 13.2% (12.7%-13.8%), ranging from 10.6% to 16.8%. In the overall cohort, there was weak correlation between 30-day RSMR and RSRR after TAVR (r=0.25, 95% CI 0.17-0.33, p<0.001). Subgroup analyses by hospital characteristics demonstrated weakest correlation between RSMR and RSRR for non-JCAHO accredited hospitals (r=0.07), hospitals in the Midwest (r=0.12) and West (r=0.14), and hospitals with low TAVR volume (r=0.15).</p><p><strong>Conclusions: </strong>Risk-standardized mortality and readmission rates after TAVR are weakly correlated, suggesting that hospital practices and processes of care influencing mortality are likely different from those influencing readmissions after TAVR, thereby necessitating measurement of both outcomes and developing specific interventions to decrease mortality and readmissions.</p>","PeriodicalId":11869,"journal":{"name":"European Heart Journal - Quality of Care and Clinical Outcomes","volume":" ","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal - Quality of Care and Clinical Outcomes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjqcco/qcae102","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is substantial hospital-level variation in 30-day risk-standardized mortality rate (RSMR) and risk-standardized readmission rate (RSRR) after transcatheter aortic valve replacement (TAVR). However, the relationship between hospital RSMRs and RSRRs has not been well characterized.

Methods: We analyzed data on 141,905 Medicare fee-for-service beneficiaries who underwent TAVR across 512 hospitals between October 1, 2015 and December 31, 2020. The primary and secondary outcomes of interest were 30-day all-cause mortality and 30-day all-cause readmissions, respectively. Hierarchical logistic regression models with random hospital-level intercepts were used to estimate RSMRs and RSRRs for each hospital. We used Pearson correlation coefficient (r) and restricted cubic spline regression to determine the relationship between RSMR and RSRR in the overall cohort and within subgroups based on hospital characteristics.

Results: The median (IQR) hospital-level 30-day RSMR was 2.2% (2.1%-2.4%), ranging from 1.3% to 3.5%. Similarly, the median (IQR) hospital-level 30-day RSRR was 13.2% (12.7%-13.8%), ranging from 10.6% to 16.8%. In the overall cohort, there was weak correlation between 30-day RSMR and RSRR after TAVR (r=0.25, 95% CI 0.17-0.33, p<0.001). Subgroup analyses by hospital characteristics demonstrated weakest correlation between RSMR and RSRR for non-JCAHO accredited hospitals (r=0.07), hospitals in the Midwest (r=0.12) and West (r=0.14), and hospitals with low TAVR volume (r=0.15).

Conclusions: Risk-standardized mortality and readmission rates after TAVR are weakly correlated, suggesting that hospital practices and processes of care influencing mortality are likely different from those influencing readmissions after TAVR, thereby necessitating measurement of both outcomes and developing specific interventions to decrease mortality and readmissions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经导管主动脉瓣置换术后住院死亡率与再住院率之间的关系。
背景:经导管主动脉瓣置换术(TAVR)后 30 天风险标准化死亡率(RSMR)和风险标准化再入院率(RSRR)在医院层面存在很大差异。然而,医院 RSMR 和 RSRR 之间的关系还没有得到很好的描述:我们分析了 2015 年 10 月 1 日至 2020 年 12 月 31 日期间在 512 家医院接受 TAVR 的 141905 名联邦医疗保险付费服务受益人的数据。主要和次要研究结果分别为 30 天全因死亡率和 30 天全因再入院率。我们使用带有随机医院级截距的层次逻辑回归模型来估计每家医院的 RSMR 和 RSRR。我们使用皮尔逊相关系数(r)和限制性三次样条回归来确定总体队列和基于医院特征的亚组中 RSMR 和 RSRR 之间的关系:医院水平的 30 天 RSMR 中位数(IQR)为 2.2%(2.1%-2.4%),范围从 1.3% 到 3.5%。同样,医院水平的 30 天 RSRR 中位数(IQR)为 13.2%(12.7%-13.8%),介于 10.6% 与 16.8% 之间。在整个队列中,TAVR后30天RSMR和RSRR之间的相关性较弱(r=0.25,95% CI 0.17-0.33,p结论:TAVR术后风险标准化死亡率和再入院率之间的相关性很弱,这表明影响死亡率的医院实践和护理流程可能不同于影响TAVR术后再入院率的实践和护理流程,因此有必要对这两种结果进行测量,并制定具体的干预措施来降低死亡率和再入院率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.40
自引率
3.80%
发文量
76
期刊介绍: European Heart Journal - Quality of Care & Clinical Outcomes is an English language, peer-reviewed journal dedicated to publishing cardiovascular outcomes research. It serves as an official journal of the European Society of Cardiology and maintains a close alliance with the European Heart Health Institute. The journal disseminates original research and topical reviews contributed by health scientists globally, with a focus on the quality of care and its impact on cardiovascular outcomes at the hospital, national, and international levels. It provides a platform for presenting the most outstanding cardiovascular outcomes research to influence cardiovascular public health policy on a global scale. Additionally, the journal aims to motivate young investigators and foster the growth of the outcomes research community.
期刊最新文献
Antithrombotic therapy following transcatheter aortic valve implantation: a Danish nationwide study. Intersectionality of inequalities in revascularisation and outcomes for acute coronary syndrome in England: nationwide linked cohort study. Assessing the Health Impact of Low Seafood Omega-3 Intake on Ischemic Heart Disease: Trends, Demographic Disparities, and Forecasts. Temporal trends of prescription rates, oral anticoagulants dose, clinical outcomes and factors associated with non-anticoagulation in patients with incident atrial fibrillation. Bariatric Surgery and Cardiovascular Outcomes in Patients with Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Coronary Artery Disease: A Population-Based Matched Cohort Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1